团队|英国两院院士领衔,中外专家畅谈AI药物发现(下)( 六 )


Question 7:
As far as you know, in what extent biologists and medical experts appreciate the assistance of AI in their research? How could biomedical science direct and enable the next phases of AI development? In other words, what types of feedback from the medical science community would be valuable to AI scientists in the coming years?
Answer:
I personally think that AI/machine learning can have transformative impacts on biological and medical research. I suspect it is underutilized at the moment and we all need to learn how to spot the opportunities. A risk is that AI-based centres are established where the links between the computational people and laboratory or clinical scientists are not as strong as they could be. Similarly, the initiatives and questions that need to be solved are often best identified by the experimental scientists and clinicians and not the computational experts. Thus, we need to seek to integrate the computational work much better within the experimental and clinical frameworks and in many cases designs
本文中的观点仅代表受访者个人观点 , 并不一定反映安永全球机构或其成员机构的观点 。

团队|英国两院院士领衔,中外专家畅谈AI药物发现(下)
文章图片

*安永研究院是应用于安永商务技能培训(上海)有限公司的知识枢纽品牌概念
本文是为提供一般信息的用途所撰写 , 并非旨在成为可依赖的会计、税务、法律或其他专业意见 。 请向您的顾问获取具体意见 。

推荐阅读